Overcoming the barriers
Clinical trials continue to experience a paucity of diversity, but it will take a multipronged approach to infuse DEI into research.
In the News
CVS’ Shuttered Clinical Trials Business Doesn’t Mean Decentralized Models Are Doomed, Exec Says
CVS Health is winding down its clinical trials business, with a full exit expected by December 31, 2024, the company confirmed to MedCity News. But decentralized clinical trials still have an important role to play, said Brian Weiss, CEO of Carebox.
